Why Diaper Rash Cream Is a Drug and Baby Lotion Is Not
How a barrier and rash-treatment diaper cream ends up classified as a drug while a plain baby lotion stays a cosmetic.
Two products sit next to each other on the same shelf, both marketed for babies, both applied to the same patch of skin, and one of them is a cosmetic while the other is legally a drug. It's a genuinely confusing split for makers who assume "baby product" is its own category. It isn't. What matters is what the product claims to do, not who it's for.
The baby lotion case
A plain baby lotion that moisturizes, softens skin, and maybe smells nice is doing exactly what a cosmetic is supposed to do: cleanse, moisturize, or beautify without treating a condition. It gets filed like any other cosmetic, a Cosmetic Notification Form through the Cosmetic Notification System, ingredients declared by INCI name with concentration ranges, checked against the Cosmetic Ingredient Hotlist for anything prohibited or restricted. Because it's marketed for infants, you'll want to be extra careful with fragrance and preservative choices even where the Hotlist doesn't strictly force your hand, since irritation tolerance is lower on infant skin. But the regulatory pathway itself is standard cosmetic notification.
The diaper rash cream case
Now take a diaper cream that says it "treats and prevents diaper rash" or "relieves and heals irritated skin." That's not a cosmetic claim anymore. Treating or preventing a condition, rash, in this case, is a therapeutic claim, and therapeutic claims push a product into drug territory. Add to that the fact that most diaper rash creams rely on an active like zinc oxide functioning as a skin protectant, and you've got a product built around treating a medical issue rather than just moisturizing over it.
This lands it in the same bucket as sunscreen, anti-acne treatments, anti-dandruff shampoo, antiperspirants, and fluoride toothpaste, all of which are typically regulated as drugs rather than cosmetics. Drug regulation is a heavier lift than cosmetic notification: different data requirements, different labeling rules, and in many cases pre-market requirements that don't apply to a straightforward cosmetic notification.
Where the line actually sits
| Product | Claim | Likely classification |
|---|---|---|
| Baby lotion, "moisturizes and softens" | Cosmetic function only | Cosmetic |
| Baby oil, "for gentle massage" | Cosmetic function only | Cosmetic |
| Diaper cream, "prevents and treats diaper rash" | Therapeutic claim | Drug |
| Barrier cream, "forms a protective layer to prevent moisture irritation" | Borderline, protective barrier without disease claim | Depends on wording and active ingredients |
| Diaper cream with zinc oxide as active, "heals irritated skin" | Therapeutic claim plus active ingredient functioning medicinally | Drug |
That middle "barrier cream" row is where a lot of makers get stuck, and it's worth being honest about: wording that stays strictly in prevention-of-irritation-from-moisture territory, without promising to heal or treat a rash, sits closer to cosmetic. Wording that promises healing or rash treatment does not. This is genuinely a case-by-case call, and if your product uses an ingredient like zinc oxide at a concentration and framing that reads as medicinal, that's a strong signal you're in drug territory regardless of how gently you word the label.
Why makers get caught out here
The instinct is to think "baby product" needs extra-careful, extra-medical-sounding language because parents want reassurance. That instinct is exactly what pushes otherwise-simple products into drug classification. A cream that says "soothes" and "moisturizes" reads very differently to a regulator than one that says "treats" and "heals," even if the formulas are nearly identical. Marketing copy matters as much as the ingredient deck.
If you're building out a baby care line, it's worth drafting your label language before you finalize your ingredient list, not after, because the claim you want to make determines which regulatory path you're on. A cosmetic notification is a notification, not a pre-market approval, and it's a much lighter lift than establishing a product as a drug.
Practical next step
If you're not sure which side of the line your product sits on, look hard at your active ingredients and your verbs. "Moisturizes," "softens," "protects skin from moisture" tend to stay cosmetic. "Treats," "heals," "relieves rash," "prevents diaper rash" tend to signal drug. When in doubt, it's worth checking directly with Health Canada rather than guessing, since the cost of filing a cosmetic notification for a product that should have been a drug submission is far higher than the few minutes it takes to check upfront.
For the cosmetic side of your baby line, once you've confirmed a product is staying in cosmetic territory, Cosmetic Comply can map your ingredients to INCI and CAS, run them against the Hotlist, and handle the CNF filing so the notification piece isn't something you're managing by hand.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Solid Perfume in a Balm Base: How the Notification Changes
A wax-based solid perfume and an alcohol eau de toilette are both fragrance, but they notify very differently on paper.
Stretch Mark Cream and the Cosmetic Versus Drug Line
How stretch mark cream wording decides whether you are filing a cosmetic notification or stepping into drug territory.
Why Fluoride Toothpaste Files as a Drug, Not a Cosmetic
Anticavity and antigingivitis claims put fluoride toothpaste in drug territory, and why that matters if you are branching into oral care.
What Extra Scrutiny Baby Lotions Face on a Notification
Why products marketed for infants draw closer ingredient review and heavier safety substantiation expectations on a Canadian filing.